ProQR Therapeutics N.V. PRQR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.15M | -15.66M | -10.38M | -12.87M | -13.82M |
| Total Depreciation and Amortization | 822.30K | 812.00K | 790.40K | 784.50K | 766.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 1.68M | 1.54M | 1.37M | 1.45M |
| Change in Net Operating Assets | -6.69M | 127.50K | -7.50M | -3.59M | -1.34M |
| Cash from Operations | -14.27M | -13.04M | -15.55M | -14.30M | -12.94M |
| Capital Expenditure | -338.50K | -191.90K | -612.30K | -197.60K | -114.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -338.50K | -191.90K | -612.30K | -197.60K | -114.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -621.00K | -304.00K | -601.00K | -444.00K | -293.00K |
| Issuance of Common Stock | 49.20M | -- | 2.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 56.50M | -355.70K | -697.30K | -519.10K | -332.50K |
| Foreign Exchange rate Adjustments | 20.90K | 337.00K | 14.00K | -39.80K | -969.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.91M | -13.25M | -16.84M | -15.06M | -14.36M |